StockData
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc. (ANRO) stock

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$25.91+1.00 (+4.01%)

Close on Nov 18, 2026Market cap $1.02BP/E –Yield –

Alto Neuroscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Alto Neuroscience

Alto Neuroscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Alto Neuroscience figures

See a number that looks wrong?